PATENT CLAIM ANALYSIS

Application Number: 15865037
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides system and methods for detecting an analyte indicative of an influenza viral infection in a sample of bodily fluid. The present invention also provides for systems and method for detection a plurality of analytes, at least two of which are indicative of an influenza viral infection in a sample of bodily fluid.

Claim (Index 79):
A method of detecting an influenza viral particle in a sample of bodily fluid using a fluidic device comprising a sample collection unit, an assay assembly, and a waste chamber, the method comprising:\n receiving the sample of bodily fluid from a subject suspected to contain the influenza viral particle at the sample collection unit of the fluidic device; providing the sample to the assay assembly of the fluidic device through the sample collection unit, wherein the assay assembly comprises a first reagent chamber, a second reagent chamber, a reaction site, and a fluidic channel that connects the first and second reagent chambers with the reaction site, and wherein the first reagent chamber comprises a first immunoassay reagent and the second reagent chamber comprises a second immunoassay reagent; releasing the first and second immunoassay reagents from the first and second reagent chambers to the reaction site of the assay assembly through the fluidic channel by one or more actuating elements; allowing the sample to react with the first and second immunoassay reagents at the reaction site of the assay assembly, wherein the first immunoassay reagent binds to a hemagglutinin molecule to form a first immune complex on the influenza viral particle, wherein the second immunoassay reagent binds to a neuraminidase molecule to form a second immune complex on the influenza viral particle, and wherein the first and second immune complexes yield one or more signals indicative of the simultaneous presence of hemagglutinin and neuraminidase on the influenza viral particle; and detecting the influenza viral particle in the sample based on detection of the one or more signals indicative of the simultaneous presence of hemagglutinin and neuraminidase.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.73529
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13187960', '11746535', '11389409', '12750518', '14868208']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588495269693641
- 35 USC 102 Novelty (BERT): 0.5852321727398749
- Combined Prediction Score: 0.7414877915464152
- Mean Citation Score: 377.66397799999993
- Max Citation Score: 544.4576400000002
- Similarity Product: 411.95879497738855

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test